Theseus Pharmaceuticals, Inc. (THRX) NASDAQ
4.07
+0.005(+0.12%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 191.68M |
| Enterprise Value | 101.05M |
| P/E Ratio | -3.32 |
| PEG Ratio | 0.21 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.75 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.68 |
Fiscal Year
| Fiscal Year | December 31, 2022 |
| Most Recent Quarter | September 30, 2023 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -0.21 |
| Return On Equity | -0.21 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -438,000 |
| EBITDA | -54.09M |
| Net Income | -47.08M |
| Diluted EPS | -1.22 |
Balance Sheet
| Total Cash | 205.12M |
| Total Cash/Share | 5.14 |
| Total Debt | 3.66M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 17.79 |
| Book Value Per Share | 5.39 |
Price History
| 52-Week Change | -47.95 |
| 52-Week High | 12.37 |
| 52-Week Low | 2.05 |
| Moving Average 50 Days | 3.95 |
| Moving Average 200 Days | 5 |
Statistics
| Average Volume | 849,600 |
| Shares Outstanding | 44.65M |
| % Held by Institutions | 0 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
